XML 137 R129.htm IDEA: XBRL DOCUMENT v3.22.0.1
Restatement of Previously Issued Financial Statements - Consolidated Statement of Cash Flows (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended
Jan. 31, 2021
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Error Corrections and Prior Period Adjustments Restatement [Line Items]          
Net loss   $ (55,951) $ (129,633)    
Depreciation and amortization   131,654 51,441    
Bad debt expense   3,122 0    
Deferred income tax benefit   163 4,214    
Share-based Compensation   1,190 16,502    
Restructuring and impairment   38,911 0    
Gain (Loss) on Foreign Currency Forward Contracts   (1,023)      
Mark to Market Loss on Contingent Shares   (25,085) 1,187    
Fair Value Adjustment of Warrants   (51,215) 55,632    
Gain (Loss) on Disposition of Business   586 0    
Increase (Decrease) in Deferred Charges   2,332 1,008    
Other Noncash Income (Expense)   3,494 (7,015)    
Increase (Decrease) in Accounts Receivable   44,221 29,279    
Increase (Decrease) in Prepaid Expense   (7,170) (7,349)    
Increase (Decrease) in Other Noncurrent Assets   (927) 54,644    
Accounts payable   13,746 758    
Accrued expenses and other current liabilities   29,082 (13,222)    
Deferred revenues   65,988 40,726    
Operating lease right of use assets   7,468 5,919    
Operating lease liabilities   (25,666) (5,876)    
Other liabilities   (883) (52,109)    
Net Cash Provided by (Used in) Operating Activities   174,037 46,106    
Capital expenditures   (32,972) (19,395)    
Payments to Acquire Businesses, Net of Cash Acquired   433 (885,323)    
Net Cash Provided by (Used in) Investing Activities   (32,539) (900,967)    
Principal payments on term loan   (7,150) (3,150)    
Proceeds from stock options exercised   5,074 1,182    
Payments related to tax withholding for stock-based compensation   (4,489) (10,420)    
Net cash (used in) provided by financing activities   (6,565) 1,091,606    
Effects of exchange rates   8,578 (2,013)    
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect   143,511 234,732    
Cash and cash equivalents   399,006 308,021 $ 257,730 $ 76,130
Restricted cash   16,913 2,850 14,678 9
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents   415,919 310,871 272,408 76,139
Cash paid for interest   27,334 11,405    
Cash paid for income tax   2,583 4,797    
Capital expenditures included in accounts payable   6,138 9,528    
Issuance of ordinary shares, net   105,509 539,714    
Share Capital          
Error Corrections and Prior Period Adjustments Restatement [Line Items]          
Issuance of ordinary shares, net   105,509 539,714    
DRG          
Error Corrections and Prior Period Adjustments Restatement [Line Items]          
Value of stock issued   61,619      
CPA Global          
Error Corrections and Prior Period Adjustments Restatement [Line Items]          
Value of stock issued $ 43,890        
Previously Reported          
Error Corrections and Prior Period Adjustments Restatement [Line Items]          
Net loss   (23,954) (74,001)    
Depreciation and amortization   131,654 51,441    
Bad debt expense   3,122      
Deferred income tax benefit   162 4,214    
Share-based Compensation   10,479 16,502    
Restructuring and impairment   40,984      
Gain (Loss) on Foreign Currency Forward Contracts   (1,023)      
Mark to Market Loss on Contingent Shares   (27,680) 1,187    
Fair Value Adjustment of Warrants   (51,215) 0    
Gain (Loss) on Disposition of Business   586      
Increase (Decrease) in Deferred Charges   2,332 1,008    
Other Noncash Income (Expense)   3,494 (7,015)    
Increase (Decrease) in Accounts Receivable   44,221 29,279    
Increase (Decrease) in Prepaid Expense   (7,170) (7,349)    
Increase (Decrease) in Other Noncurrent Assets   (927) 54,644    
Accounts payable   13,746 758    
Accrued expenses and other current liabilities   (9,725) (12,035)    
Deferred revenues   65,988 40,726    
Operating lease right of use assets   7,468 5,919    
Operating lease liabilities   (25,666) (5,876)    
Other liabilities   (2,839) (52,109)    
Net Cash Provided by (Used in) Operating Activities   174,037 46,106    
Capital expenditures   (32,972) (19,395)    
Payments to Acquire Businesses, Net of Cash Acquired   433 (885,323)    
Net Cash Provided by (Used in) Investing Activities   (32,539) (900,967)    
Principal payments on term loan   (7,150) (3,150)    
Proceeds from stock options exercised   5,074      
Payments related to tax withholding for stock-based compensation   (4,489) (10,420)    
Net cash (used in) provided by financing activities   (6,565) 1,091,606    
Effects of exchange rates   8,578 (2,013)    
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect   143,511 234,732    
Cash and cash equivalents   399,006 308,021 257,730 76,130
Restricted cash   13,513 2,850 11,278 9
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents   412,519 310,871 269,008 $ 76,139
Cash paid for interest   27,334 11,405    
Cash paid for income tax   2,583 4,797    
Capital expenditures included in accounts payable   6,138 $ 9,528    
Revision of Prior Period, Reclassification, Adjustment          
Error Corrections and Prior Period Adjustments Restatement [Line Items]          
Net loss   (31,997)      
Depreciation and amortization   0      
Bad debt expense   0      
Deferred income tax benefit   1      
Share-based Compensation   (9,289)      
Restructuring and impairment   (2,073)      
Gain (Loss) on Foreign Currency Forward Contracts   0      
Mark to Market Loss on Contingent Shares   2,595      
Fair Value Adjustment of Warrants   0      
Gain (Loss) on Disposition of Business   0      
Increase (Decrease) in Deferred Charges   0      
Other Noncash Income (Expense)   0      
Increase (Decrease) in Accounts Receivable   0      
Increase (Decrease) in Prepaid Expense   0      
Increase (Decrease) in Other Noncurrent Assets   0      
Accounts payable   0      
Accrued expenses and other current liabilities   38,807      
Deferred revenues   0      
Operating lease right of use assets   0      
Operating lease liabilities   0      
Other liabilities   1,956      
Net Cash Provided by (Used in) Operating Activities   0      
Capital expenditures   0      
Payments to Acquire Businesses, Net of Cash Acquired   0      
Net Cash Provided by (Used in) Investing Activities   0      
Principal payments on term loan   0      
Proceeds from stock options exercised   0      
Payments related to tax withholding for stock-based compensation   0      
Net cash (used in) provided by financing activities   0      
Effects of exchange rates   0      
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect   0      
Cash and cash equivalents   0   0  
Restricted cash   3,400   3,400  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents   3,400   $ 3,400  
Cash paid for interest   0      
Cash paid for income tax   0      
Capital expenditures included in accounts payable   0      
Revision of Prior Period, Reclassification, Adjustment | Share Capital          
Error Corrections and Prior Period Adjustments Restatement [Line Items]          
Issuance of ordinary shares, net   105,509      
Revision of Prior Period, Reclassification, Adjustment | DRG          
Error Corrections and Prior Period Adjustments Restatement [Line Items]          
Value of stock issued   $ 61,619      
Revision of Prior Period, Reclassification, Adjustment | CPA Global          
Error Corrections and Prior Period Adjustments Restatement [Line Items]          
Value of stock issued $ 43,890